David Vigerust
Last active: 6/25/2020

Profile

Dr. Vigerust’s academic and research interests focus around areas of precision medicine, diagnostics, infectious disease, traumatic brain injury, and neuroinflammation.

I have a particular interest in the role of neuroinflammation  in the development of meningioma. I also have a significant research and clinical interest in respiratory and wound infectious disease

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Microvascular disease confers additional risk to COVID-19 infection. Bale BF, Doneen AL, Vigerust DJ (2020) Med Hypotheses : 109999
    › Primary publication · 32570168 (PubMed) · PMC7294251 (PubMed Central)
  2. Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification. Doneen AL, Bale BF, Vigerust DJ, Leimgruber PP (2020) Front Cardiovasc Med : 92
    › Primary publication · 32528979 (PubMed) · PMC7256212 (PubMed Central)
  3. Protein glycosylation in infectious disease pathobiology and treatment. Vigerust DJ (2011) Cent Eur J Biol 6(5): 802
    › Primary publication · 32215117 (PubMed) · PMC7088636 (PubMed Central)
  4. Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping. Bale BF, Doneen AL, Vigerust DJ (2018) Front Cardiovasc Med : 141
    › Primary publication · 30386783 (PubMed) · PMC6198642 (PubMed Central)
  5. High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Bale BF, Doneen AL, Vigerust DJ (2017) Postgrad Med J 93(1098): 215-220
    › Primary publication · 27899684 (PubMed) · PMC5520251 (PubMed Central)
  6. Role of Haptoglobin in Health and Disease: A Focus on Diabetes. MacKellar M, Vigerust DJ (2016) Clin Diabetes 34(3): 148-57
    › Primary publication · 27621532 (PubMed) · PMC5019011 (PubMed Central)
  7. Hp: an inflammatory indicator in cardiovascular disease. Graves KL, Vigerust DJ (2016) Future Cardiol 12(4): 471-81
    › Primary publication · 27203711 (PubMed)
  8. Stable Expression and Characterization of an Optimized Mannose Receptor. Vigerust DJ, Vick S, Shepherd VL (2015) J Clin Cell Immunol 6(3)
    › Primary publication · 26581716 (PubMed) · PMC4645283 (PubMed Central)
  9. Interaction of members of the heat shock protein-70 family with the macrophage mannose receptor. Yang S, Vigerust DJ, Shepherd VL (2013) J Leukoc Biol 93(4): 529-36
    › Primary publication · 23345393 (PubMed) · PMC3597836 (PubMed Central)
  10. Characterization of functional mannose receptor in a continuous hybridoma cell line. Vigerust DJ, Vick S, Shepherd VL (2012) BMC Immunol : 51
    › Primary publication · 22967244 (PubMed) · PMC3495026 (PubMed Central)
  11. First complete and productive cell culture model for members of the genus Iridovirus. D'Costa SM, Vigerust DJ, Perales-Hull MR, Lodhi SA, Viravathana P, Bilimoria SL (2012) Arch Virol 157(11): 2171-8
    › Primary publication · 22828780 (PubMed)
  12. Mitogen-activated protein kinases and NFkappaB are involved in SP-A-enhanced responses of macrophages to mycobacteria. Lopez JP, Vigerust DJ, Shepherd VL (2009) Respir Res : 60
    › Primary publication · 19566962 (PubMed) · PMC2717924 (PubMed Central)
  13. Chloroquine is effective against influenza A virus in vitro but not in vivo. Vigerust DJ, McCullers JA (2007) Influenza Other Respir Viruses 1(5-6): 189-92
    › Primary publication · 19453426 (PubMed) · PMC4941887 (PubMed Central)
  14. N-linked glycosylation attenuates H3N2 influenza viruses. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA (2007) J Virol 81(16): 8593-600
    › Primary publication · 17553891 (PubMed) · PMC1951338 (PubMed Central)
  15. Virus glycosylation: role in virulence and immune interactions. Vigerust DJ, Shepherd VL (2007) Trends Microbiol 15(5): 211-8
    › Primary publication · 17398101 (PubMed) · PMC7127133 (PubMed Central)
  16. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor. Vigerust DJ, Egan BS, Shepherd VL (2005) J Leukoc Biol 77(4): 522-34
    › Primary publication · 15637102 (PubMed)
  17. Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Gelderman MP, Stuart R, Vigerust D, Fuhrmann S, Lefkowitz DL, Allen RC, Lefkowitz SS, Graham S (1998) Mediators Inflamm 7(6): 381-9
    › Primary publication · 9927230 (PubMed) · PMC1781873 (PubMed Central)